ClinConnect ClinConnect Logo
Search / Trial NCT03765970

Transcultural Validation of MSTS and TESS Questionnaire

Launched by NANTES UNIVERSITY HOSPITAL · Dec 4, 2018

Trial Information

Current as of May 24, 2025

Unknown status

Keywords

Tumor Resection Msts Tess Soft Tissue And Bone Questionnaires

ClinConnect Summary

The methodology will follow the guidelines of Dorcas E. Beaton, Claire Bombardier, Francis Guillemin and Marcos Bosi Ferraz (approved in particular by the American Academy of Orthopedic Surgeons):

Step 1: Author's agreement Step 2: Translation with cultural adaptation in addition to literal translation Step 3: 2 first translations English to French (2 different translators T1 and T2) Step 4: Synthesis (T12) Step 5: 2 reverse translations of T12 French to English (BT1 and BT2) Step 6: Submission to a committee of experts of the final translation Step 7: Clinical study based on a sample of p...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Major Patients who has accepted and be informed of the protocol or minor patient over 15 years old who has accepted and be informed of the protocol, with the agreement of one legal representative
  • Patients over 15 years old who had a surgical procedure for a musculoskeletal tumor which could result in functional sequels. (at the appreciation of the surgeon)
  • Patients in the capacity to answer and understand the questionnaire and for whom the French is the native language
  • Exclusion Criteria:
  • Patients refusing to participate
  • Patient under guardianship
  • Patient inappropriate for entry into this study according to the judgment of the investigator

About Nantes University Hospital

Nantes University Hospital, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific exploration with patient care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Nantes University Hospital aims to contribute to the development of effective therapies and interventions that enhance patient outcomes and overall public health.

Locations

Nantes, , France

Rennes, , France

Tours, , France

Marseille, , France

Patients applied

0 patients applied

Trial Officials

Kevin BRULEFERT, Dr

Principal Investigator

Nantes University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials